Octrooien

In general, the disclosure relates to a fluid conduit device, such as microfluidic technique, with minimal operation. More specifically, the present invention relates to an activation and pressure balancing mechanism suitable for robust activation of fluid conduit devices.

In general, the disclosure relates to a fluid conduit device, such as microfluidic technique, with minimal operation. More specifically, the present invention relates to an activation and pressure balancing mechanism suitable for robust activation of fluid conduit devices.

The current invention relates to a compound of Formula (I) or a stereoisomer, tautomer, racemic, metabolite, prodrug, salt, hydrate, or solvate thereof, The invention also relates to a pharmaceutical composition comprising said compound. The invention also relates to said pharmaceutical composition or said compound for use as a medicine, for use in the prevention and/or treatment of diseases.

Described herein is a method and system for mitigating the effects of speckle in a laser Doppler system, and, in particular in a laser Doppler vibrometry/velocimetry system. A scan unit is provided in at least one of: a transmit path for scanning at least one beam from a transmitting antenna over a moving target surface and a receive path for scanning at least one reflected beam received from the moving target surface onto a receiving antenna. An averaging unit is provided prior to post-processing or demodulation to average electrical signals corresponding to the reflected beams. By averaging ...

Described herein is a method and system for mitigating the effects of speckle in a laser Doppler system, and, in particular in a laser Doppler vibrometry/velocimetry system. A scan unit is provided in at least one of: a transmit path for scanning at least one beam from a transmitting antenna over a moving target surface and a receive path for scanning at least one reflected beam received from the moving target surface onto a receiving antenna. An averaging unit is provided prior to post-processing or demodulation to average electrical signals corresponding to the reflected beams. By averaging ...

Described herein is a method and system for mitigating the effects of speckle in a laser Doppler system, and, in particular in a laser Doppler vibrometry/velocimetry system. A scan unit (225, 230) is provided in at least one of: a transmit path for scanning at least one beam from a transmitting antenna (125) over a moving target surface (190) and a receive path for scanning at least one reflected beam (230a) received from the moving target surface onto a receiving antenna (230). An averaging unit (265) is provided prior to post-processing or demodulation to average electrical signals ...

Described herein is a method and system for mitigating the effects of speckle in a laser Doppler system, and, in particular in a laser Doppler vibrometry/velocimetry system. A scan unit (225, 230) is provided in at least one of: a transmit path for scanning at least one beam from a transmitting antenna (125) over a moving target surface (190) and a receive path for scanning at least one reflected beam (230a) received from the moving target surface onto a receiving antenna (230). An averaging unit (265) is provided prior to post-processing or demodulation to average electrical signals ...

The present invention relates to an isolated fructose-1,6-bisphosphate / SOS complex. The invention relates further to the use of the complex to screen for compounds that modulate the activation of Ras, and the use of yeast strains for said screening. The invention relates also to compounds, disrupting the fructose-1,6-bisphosphate / SOS complex and the use of such compounds in the treatment of cancer.

The present invention relates to novel compounds of formula (la), to said compounds for use as a medicine, more in particular for the prevention or treatment of diseases mediated by activity of YAP/ TAZ-TEAD transcription, yet more in particular for the prevention or treatment of cancer or fibrosis. The present invention also relates to a method for the prevention or treatment of said diseases comprising the use of the novel compounds. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the novel compounds as well as to said compositions or ...

A semiconductor device comprises a substrate, a first hole-transporting layer over the substrate, a first electron-transporting layer on the first hole-transporting layer, and a second hole-transporting layer over the first electron-transporting layer.. At least one of the first electron-transporting layer and the second hole-transporting layer has an organic component. The device is characterized by one of the following: a metal oxide layer present on the first electron-transporting layer, wherein a second electron-transporting layer is on the metal oxide layer, wherein the second ...